Location History:
- Rüdlingen, CH (2010 - 2011)
- Rudlingen, CH (2019)
Company Filing History:
2 out of 2 
1 out of 15 
1 out of 164 
Years Active: 2010-2019
Title: The Innovations of Hans Lutz
Introduction
Hans Lutz is a notable inventor based in Rüdlingen, Switzerland. He has made significant contributions to the field of veterinary medicine, particularly in the diagnosis and prevention of feline diseases. With a total of 4 patents, his work has had a meaningful impact on the health of cats.
Latest Patents
One of his latest patents is focused on the Feline leukemia virus trans-membrane protein p15E for the diagnosis of FeLV infection. This invention provides a method for detecting FeLV infection in a patient by contacting a sample obtained from the patient in-vitro with a recombinant transmembrane p15E protein during a p15 (E) antibody binding step. Another significant patent is a vaccine against oncovirus infections, specifically targeting infections caused by the feline leukosis virus. This vaccine is designed to induce protection against disease resulting from lentivirus infections and comprises codon-optimized DNA sequences encoding structural proteins and the essential membrane protein of FeLV.
Career Highlights
Hans Lutz has worked with reputable organizations, including the University of Zurich Veterinary Clinical Laboratory and Mologen AG. His experience in these institutions has allowed him to advance his research and contribute to the development of innovative solutions for feline health issues.
Collaborations
Throughout his career, Hans has collaborated with esteemed colleagues such as Regina Hofmann-Lehmann and Barbara Willi. These partnerships have further enriched his research and innovations in the field.
Conclusion
Hans Lutz's contributions to veterinary medicine through his patents and collaborations highlight his dedication to improving feline health. His innovative approaches continue to pave the way for advancements in the diagnosis and prevention of feline diseases.